Humacyte (HUMA) Earnings Date, Estimates & Call Transcripts $1.48 +0.01 (+0.54%) As of 10:29 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Humacyte Earnings Summary Upcoming Earnings DateMay. 9Before Market OpensEstimatedConsensus EPS (Mar. 28) -$0.23 Actual EPS (Mar. 28) -$0.16 Beat By $0.07 Actual Revenue (Mar. 28) $7.23MHumacyte released Q4 2024 earnings on March 28, 2025, reporting an EPS of -$0.16, which topped analysts' consensus estimates of -$0.23 by $0.07. Quarterly revenue was reported to be $7.23 million, above the consensus estimate of $0.64 million. With a trailing EPS of -$1.26, Humacyte's earnings are expected to grow next year, from ($1.27) to ($0.83) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)HUMA Upcoming EarningsHumacyte's Q1 2025 earnings is scheduled for Friday, May 9, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Humacyte Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Humacyte and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHUMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HUMA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Humacyte Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.27) EPSNext Year EPS Consensus Estimate ($0.83) EPS Humacyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/9/2025(Estimated)-------3/28/2025Q4 2024-$0.23-$0.16+$0.07-$0.16$0.64M$7.23M11/8/2024Q3 2024-$0.25-$0.33 -$0.08-$0.33--8/13/2024Q2 2024-$0.23-$0.27 -$0.04-$0.06--5/10/2024Q1 2024-$0.23-$0.29 -$0.06-$0.29--3/22/2024Q4 2023-$0.25-$0.24+$0.01-$0.24$0.10M-11/9/2023Q3 2023-$0.25-$0.25--$0.25--8/14/2023Q2 2023-$0.22-$0.22--$0.22$0.10M-5/12/2023Q1 2023-$0.22-$0.22--$0.08-- Humacyte Earnings - Frequently Asked Questions When is Humacyte's earnings date? Humacyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on HUMA's earnings history. Did Humacyte beat their earnings estimates last quarter? In the previous quarter, Humacyte (NASDAQ:HUMA) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.07. Learn more on analysts' earnings estimate vs. HUMA's actual earnings. How can I listen to Humacyte's earnings conference call? The conference call for Humacyte's latest earnings report can be listened to online. Listen to Conference Call How can I read Humacyte's conference call transcript? The conference call transcript for Humacyte's latest earnings report can be read online. Read Transcript How much revenue does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded annual revenue of $1.57 million. How much profit does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded net income of -$110.78 million. HUMA has generated -$1.26 earnings per share over the last four quarters. What is Humacyte's EPS forecast for next year? Humacyte's earnings are expected to grow from ($1.27) per share to ($0.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Collegium Pharmaceutical Earnings Mineralys Therapeutics Earnings Intellia Therapeutics Earnings Spyre Therapeutics Earnings Zymeworks Earnings Arcus Biosciences Earnings Nurix Therapeutics Earnings Chimerix Earnings Avid Bioservices Earnings Enliven Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock?Genuine Parts: Solid Earnings But Economic Uncertainties RemainBreaking Down Taiwan Semiconductor's Earnings and Future Upside This page (NASDAQ:HUMA) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HUMA Stock Free HUMA Stock Alerts